Clinical trial
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal…
NCT00391417 · BioSante Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00391417 |
|---|---|
| Title | Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms |
| Official title | Phase III, Multicenter, Double-Blind Study of the Safety and Efficacy of Bio-E-Gel (Topical Estradiol Gel) Versus Placebo for Treatment of Vasomotor Symptoms and Vulvovaginal Atrophy in Postmenopausal Females |
| Lead sponsor | BioSante Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug |
| Interventions | estradiol gel |
| Enrollment | 431 |
| Start date | Sep 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Oct 24, 2006 |
| Last update posted | Oct 24, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: